• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

CDC Awards Truveta Real-World Data Contract to Study COVID, Maternal Health, Pediatric Care

by Fred Pennic 01/23/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
public

What You Should Know:

– Truveta, a consortium of 30 health systems united in “Saving Lives with Data,” has secured a significant partnership with the U.S. Centers for Disease Control and Prevention (CDC).

– This collaboration will leverage Truveta’s vast repository of real-world healthcare data to empower CDC researchers in tackling pressing public health challenges, including COVID-19, maternal health, and pediatric care.

Unprecedented Data Access for COVID-19 Insights

Truveta will provide the CDC with access to anonymized electronic health record (EHR) data from over 100 million patients, offering a comprehensive and timely snapshot of real-world healthcare experiences. This unprecedented access will equip CDC researchers with novel insights into:

  • SARS-CoV-2 variants: Understanding the spread and impact of new variants is crucial for informing public health measures and vaccine strategies.
  • Vaccinations and testing: Truveta’s data can reveal the effectiveness of vaccination and testing programs, helping optimize resource allocation and improve public health outcomes.
  • Re-infection and long-term effects: Studying re-infection patterns and long-term health impacts of COVID-19 will be vital for developing effective treatment strategies and managing long-term consequences.

Beyond COVID-19: Maternal and Pediatric Health Research

The collaboration extends beyond COVID-19, providing valuable data for research on critical areas like maternal and pediatric health. This includes:

  • Maternal health: Truveta’s data can shed light on pregnancy and childbirth complications, leading to improved prenatal care and maternal health outcomes.
  • Pediatric care: Studying childhood illnesses and healthcare utilization through Truveta’s data can inform preventive measures and optimize pediatric care delivery.

“As the coronavirus pandemic began ravaging our country and the world, Truveta was formed in 2020 to bring together data that would enable faster answers and better care,” said Truveta CEO Terry Myerson. “This is a full-circle moment for Truveta to provide the CDC with regulatory-grade data and powerful analytics to enable scientifically rigorous research on COVID and other major public health concerns that improves care for us all. We are honored that our unique data will help the CDC advance its mission of working 24/7 to save lives and protect people.” 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Public Health, real-world data (RWD)

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |